1. Home
  2. SPRC vs CNSP Comparison

SPRC vs CNSP Comparison

Compare SPRC & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • CNSP
  • Stock Information
  • Founded
  • SPRC 2004
  • CNSP 2017
  • Country
  • SPRC Israel
  • CNSP United States
  • Employees
  • SPRC N/A
  • CNSP N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • CNSP Health Care
  • Exchange
  • SPRC Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • SPRC 4.3M
  • CNSP 4.0M
  • IPO Year
  • SPRC N/A
  • CNSP 2019
  • Fundamental
  • Price
  • SPRC $2.78
  • CNSP $8.13
  • Analyst Decision
  • SPRC
  • CNSP Strong Buy
  • Analyst Count
  • SPRC 0
  • CNSP 1
  • Target Price
  • SPRC N/A
  • CNSP $20.00
  • AVG Volume (30 Days)
  • SPRC 289.9K
  • CNSP 18.4K
  • Earning Date
  • SPRC 01-01-0001
  • CNSP 11-12-2025
  • Dividend Yield
  • SPRC N/A
  • CNSP N/A
  • EPS Growth
  • SPRC N/A
  • CNSP N/A
  • EPS
  • SPRC N/A
  • CNSP N/A
  • Revenue
  • SPRC $1,306,000.00
  • CNSP N/A
  • Revenue This Year
  • SPRC N/A
  • CNSP N/A
  • Revenue Next Year
  • SPRC N/A
  • CNSP N/A
  • P/E Ratio
  • SPRC N/A
  • CNSP N/A
  • Revenue Growth
  • SPRC N/A
  • CNSP N/A
  • 52 Week Low
  • SPRC $1.75
  • CNSP $4.93
  • 52 Week High
  • SPRC $37.59
  • CNSP $114.00
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 37.96
  • CNSP 40.01
  • Support Level
  • SPRC $2.51
  • CNSP $6.13
  • Resistance Level
  • SPRC $3.40
  • CNSP $8.86
  • Average True Range (ATR)
  • SPRC 0.22
  • CNSP 0.59
  • MACD
  • SPRC -0.08
  • CNSP -0.12
  • Stochastic Oscillator
  • SPRC 17.47
  • CNSP 22.34

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: